APGE logo

Apogee Therapeutics (APGE) EBIT

Annual EBIT

-$216.87 M
-$123.87 M-133.19%

December 31, 2024


Summary


Performance

APGE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPGEprofitabilitymetrics:

Quarterly EBIT

-$75.88 M
-$17.20 M-29.30%

December 31, 2024


Summary


Performance

APGE Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPGEprofitabilitymetrics:

TTM EBIT

-$216.87 M
-$38.73 M-21.74%

December 31, 2024


Summary


Performance

APGE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPGEprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

APGE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-133.2%0.0%0.0%
3 y3 years-607.9%-301.8%-286.9%
5 y5 years-607.9%-301.8%-286.9%

APGE EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-607.9%at low-4078.5%at low<-9999.0%at low
5 y5-year-607.9%at low-4078.5%at low<-9999.0%at low
alltimeall time-607.9%at low-4078.5%at low<-9999.0%at low

Apogee Therapeutics EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-$216.87 M(+133.2%)
-$75.88 M(+29.3%)
-$216.87 M(+21.7%)
Sep 2024
-
-$58.69 M(+33.0%)
-$178.14 M(+23.9%)
Jun 2024
-
-$44.12 M(+15.6%)
-$143.76 M(+21.3%)
Mar 2024
-
-$38.18 M(+2.8%)
-$118.53 M(+27.4%)
Dec 2023
-$93.00 M
-$37.16 M(+52.9%)
-$93.00 M(+33.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$24.30 M(+28.7%)
-$69.86 M(+24.6%)
Jun 2023
-
-$18.89 M(+49.2%)
-$56.06 M(+43.8%)
Mar 2023
-
-$12.66 M(-9.6%)
-$38.99 M(+48.1%)
Dec 2022
-$30.64 M
-$14.01 M(+33.3%)
-$26.33 M(+113.7%)
Sep 2022
-
-$10.51 M(+478.6%)
-$12.32 M(+578.6%)
Jun 2022
-
-$1.82 M
-$1.82 M

FAQ

  • What is Apogee Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics annual EBIT year-on-year change?
  • What is Apogee Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics quarterly EBIT year-on-year change?
  • What is Apogee Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Apogee Therapeutics?
  • What is Apogee Therapeutics TTM EBIT year-on-year change?

What is Apogee Therapeutics annual earnings before interest & taxes?

The current annual EBIT of APGE is -$216.87 M

What is the all time high annual EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high annual earnings before interest & taxes is -$30.64 M

What is Apogee Therapeutics annual EBIT year-on-year change?

Over the past year, APGE annual earnings before interest & taxes has changed by -$123.87 M (-133.19%)

What is Apogee Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of APGE is -$75.88 M

What is the all time high quarterly EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high quarterly earnings before interest & taxes is -$1.82 M

What is Apogee Therapeutics quarterly EBIT year-on-year change?

Over the past year, APGE quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Apogee Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of APGE is -$216.87 M

What is the all time high TTM EBIT for Apogee Therapeutics?

Apogee Therapeutics all-time high TTM earnings before interest & taxes is -$1.82 M

What is Apogee Therapeutics TTM EBIT year-on-year change?

Over the past year, APGE TTM earnings before interest & taxes has changed by $0.00 (0.00%)